National Health and Medical Industry Growth Plan – Australian Genomics Health Futures Mission

Page last updated: 08 May 2018

National Health and Medical Industry Growth Plan – Australian Genomics Health Futures Mission (PDF 125 KB)

The Government will invest $1.3 billion in a Health and Medical Industry Growth Plan. The Government will invest $500 million over 10 years in an Australian Genomics Mission to help save or transform the lives of more than 200,000 Australians through research into better testing, diagnosis and treatment. Key features of the Australian Genomics Mission include:

  • new and expanded clinical flagship studies to tackle rare diseases, rare cancers and complex conditions;
  • new clinical trials and technology applications allowing Australian patients to benefit from the latest medical research;
  • increased academic and researcher collaboration and new career pathways;
  • co-investment with philanthropy and business to support new industries;
  • community dialogue to better understand the value of genomics and gain appreciation of the privacy, legal, social and familial impact; and
  • analytical power backed by national standards and protocols that ensure secure data holdings, access, analysis and sharing to benefit Australians.
The first project will be ‘Mackenzie’s Mission’ – a new $20 million trial in pre-conception screening for rare and debilitating genetic birth disorders, such as Spinal Muscular Atrophy, providing vital information and hope for hundreds of parents who face difficult choices in starting a family.

Why is this important?

Genomics – precision medical care that targets the unique genetic make-up of individuals – is set to revolutionise healthcare. It will lead to better prevention, prediction and diagnosis of disease, and improved treatment, management and cures.

Australia has the right capabilities for success – excellent research talent, innovative businesses and a genomics workforce that is already internationally highly regarded.

Who will benefit?

The Mission will help Australians to live longer and better through access to genomics knowledge and technology, and bring hope to Australians suffering untreatable and life threatening diseases and cancers. It will position Australia as a global leader in genomics research, investment and technology.

How much will this cost?

This will cost $500 million from 2017–18 to 2026–27 from the MRFF.

In this section